Why strong science isn’t enough to raise capital

There’s a moment most biotech founders know well. The science is solid. The team is credible. The data is strong. And yet, somewhere between the pitch deck and the term […]

There’s a moment most biotech founders know well. The science is solid. The team is credible. The data is strong. And yet, somewhere between the pitch deck and the term […]